Jeffrey D. Dvorin, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protozoan Proteins | 22 | 2023 | 827 | 5.830 |
Why?
|
| Plasmodium falciparum | 32 | 2023 | 1732 | 5.540 |
Why?
|
| Malaria, Falciparum | 15 | 2023 | 1077 | 3.660 |
Why?
|
| Cytokinesis | 6 | 2021 | 177 | 2.810 |
Why?
|
| Parasites | 6 | 2023 | 163 | 2.420 |
Why?
|
| Erythrocytes | 15 | 2023 | 2455 | 1.800 |
Why?
|
| Schizonts | 7 | 2021 | 22 | 1.750 |
Why?
|
| Plasmodium | 3 | 2023 | 250 | 1.570 |
Why?
|
| Malaria | 10 | 2023 | 1239 | 1.400 |
Why?
|
| Life Cycle Stages | 5 | 2022 | 160 | 1.380 |
Why?
|
| Calcium-Binding Proteins | 4 | 2020 | 1081 | 1.270 |
Why?
|
| Protein Kinases | 4 | 2020 | 1640 | 1.110 |
Why?
|
| Merozoites | 5 | 2020 | 64 | 0.970 |
Why?
|
| Toxoplasma | 3 | 2021 | 150 | 0.930 |
Why?
|
| Gametogenesis | 1 | 2022 | 26 | 0.860 |
Why?
|
| Cell Nucleus Division | 1 | 2020 | 10 | 0.780 |
Why?
|
| Actomyosin | 1 | 2021 | 111 | 0.740 |
Why?
|
| Antimalarials | 4 | 2022 | 905 | 0.650 |
Why?
|
| Cell Division | 3 | 2023 | 4568 | 0.650 |
Why?
|
| Contractile Proteins | 1 | 2019 | 246 | 0.630 |
Why?
|
| Artemisinins | 1 | 2020 | 221 | 0.620 |
Why?
|
| Cyclin H | 1 | 2017 | 5 | 0.620 |
Why?
|
| Malaria, Cerebral | 1 | 2017 | 135 | 0.550 |
Why?
|
| Phosphoproteins | 2 | 2020 | 2440 | 0.400 |
Why?
|
| Host-Parasite Interactions | 4 | 2021 | 295 | 0.370 |
Why?
|
| Proteome | 1 | 2020 | 1799 | 0.350 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 1655 | 0.350 |
Why?
|
| Receptors, Cell Surface | 2 | 2016 | 2866 | 0.310 |
Why?
|
| Antigens, Protozoan | 3 | 2021 | 322 | 0.300 |
Why?
|
| Antibodies, Protozoan | 3 | 2020 | 253 | 0.290 |
Why?
|
| Time-Lapse Imaging | 2 | 2019 | 195 | 0.290 |
Why?
|
| HIV Integrase | 2 | 2002 | 120 | 0.250 |
Why?
|
| Virus Integration | 2 | 2003 | 299 | 0.240 |
Why?
|
| Cell Nucleus | 3 | 2003 | 2969 | 0.240 |
Why?
|
| Ascomycota | 1 | 2023 | 82 | 0.220 |
Why?
|
| Culicidae | 1 | 2023 | 105 | 0.220 |
Why?
|
| Microtubule-Organizing Center | 1 | 2020 | 26 | 0.190 |
Why?
|
| Animals | 17 | 2023 | 168757 | 0.190 |
Why?
|
| Drug Design | 3 | 2022 | 1076 | 0.170 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2020 | 214 | 0.160 |
Why?
|
| Trypanosoma cruzi | 1 | 2020 | 198 | 0.150 |
Why?
|
| Reproduction, Asexual | 1 | 2017 | 15 | 0.150 |
Why?
|
| Malaria Vaccines | 2 | 2020 | 158 | 0.150 |
Why?
|
| Genetic Techniques | 1 | 2020 | 435 | 0.150 |
Why?
|
| Chromosomes | 1 | 2020 | 596 | 0.150 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 712 | 0.150 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2021 | 1369 | 0.140 |
Why?
|
| Structure-Activity Relationship | 3 | 2020 | 3129 | 0.140 |
Why?
|
| Carrier State | 1 | 2020 | 518 | 0.140 |
Why?
|
| DNA, Viral | 2 | 2002 | 2225 | 0.140 |
Why?
|
| Cytochromes c | 1 | 2017 | 180 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7880 | 0.140 |
Why?
|
| HIV-1 | 3 | 2003 | 6939 | 0.140 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 853 | 0.140 |
Why?
|
| CDC2 Protein Kinase | 1 | 2017 | 220 | 0.140 |
Why?
|
| Molecular Structure | 1 | 2020 | 1899 | 0.130 |
Why?
|
| Phagocytosis | 1 | 2021 | 1539 | 0.130 |
Why?
|
| Drug Resistance | 1 | 2020 | 1609 | 0.120 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2017 | 671 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2012 | 3772 | 0.110 |
Why?
|
| Ligands | 2 | 2010 | 3282 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1676 | 0.110 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 2645 | 0.110 |
Why?
|
| Ribosomes | 1 | 2015 | 500 | 0.100 |
Why?
|
| Thiazepines | 1 | 2011 | 30 | 0.100 |
Why?
|
| Electron Transport Complex III | 1 | 2011 | 31 | 0.100 |
Why?
|
| Cell Cycle | 2 | 2017 | 2967 | 0.100 |
Why?
|
| Drosophila melanogaster | 1 | 2021 | 1708 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2020 | 4161 | 0.100 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2008 | 281 | 0.100 |
Why?
|
| Humans | 23 | 2023 | 744343 | 0.090 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2010 | 30 | 0.090 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 2 | 2008 | 167 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 4 | 2012 | 3846 | 0.090 |
Why?
|
| Exocytosis | 1 | 2012 | 353 | 0.090 |
Why?
|
| Enzyme Inhibitors | 3 | 2010 | 3798 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2021 | 2752 | 0.090 |
Why?
|
| DNA Replication | 1 | 2017 | 1399 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 2916 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2020 | 3748 | 0.090 |
Why?
|
| Organelles | 1 | 2012 | 264 | 0.090 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 5524 | 0.090 |
Why?
|
| Asparagine | 1 | 2009 | 122 | 0.090 |
Why?
|
| NADH Dehydrogenase | 1 | 2008 | 41 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 2699 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2020 | 8436 | 0.080 |
Why?
|
| Microscopy | 2 | 2023 | 903 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2021 | 19229 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 2126 | 0.080 |
Why?
|
| Electron Transport | 1 | 2008 | 211 | 0.080 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2017 | 1888 | 0.080 |
Why?
|
| Morpholines | 1 | 2010 | 571 | 0.070 |
Why?
|
| Virus Replication | 3 | 2003 | 2534 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 198 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 5853 | 0.070 |
Why?
|
| Kenya | 2 | 2020 | 685 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2010 | 1586 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 2009 | 914 | 0.060 |
Why?
|
| Tanzania | 2 | 2020 | 1346 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2002 | 443 | 0.060 |
Why?
|
| Archaeology | 1 | 2023 | 37 | 0.060 |
Why?
|
| Apoptosis | 1 | 2020 | 9727 | 0.060 |
Why?
|
| Pyrroles | 1 | 2010 | 1146 | 0.060 |
Why?
|
| Gene Expression | 1 | 2016 | 7799 | 0.060 |
Why?
|
| Polysaccharides | 1 | 2009 | 1053 | 0.050 |
Why?
|
| Community-Acquired Infections | 1 | 2006 | 465 | 0.050 |
Why?
|
| Nuclear Localization Signals | 1 | 2001 | 80 | 0.050 |
Why?
|
| Immunological Synapses | 1 | 2021 | 54 | 0.050 |
Why?
|
| Trophozoites | 1 | 2020 | 12 | 0.050 |
Why?
|
| Aotidae | 1 | 2020 | 59 | 0.050 |
Why?
|
| Gene Products, env | 1 | 2001 | 263 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2023 | 729 | 0.040 |
Why?
|
| Mutation | 4 | 2017 | 29786 | 0.040 |
Why?
|
| DNA, Protozoan | 1 | 2020 | 237 | 0.040 |
Why?
|
| Vacuoles | 1 | 2020 | 230 | 0.040 |
Why?
|
| Granzymes | 1 | 2021 | 271 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2002 | 2050 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 12072 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2021 | 906 | 0.040 |
Why?
|
| Calcium | 1 | 2012 | 5756 | 0.040 |
Why?
|
| Pyridines | 1 | 2010 | 2825 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 1451 | 0.040 |
Why?
|
| Mali | 1 | 2017 | 44 | 0.040 |
Why?
|
| Organisms, Genetically Modified | 1 | 2017 | 64 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 1400 | 0.040 |
Why?
|
| Caspases | 1 | 2020 | 928 | 0.040 |
Why?
|
| Senegal | 1 | 2017 | 294 | 0.040 |
Why?
|
| Models, Biological | 2 | 2010 | 9583 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 23403 | 0.040 |
Why?
|
| Brazil | 1 | 2021 | 1270 | 0.040 |
Why?
|
| Models, Chemical | 2 | 2008 | 626 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2002 | 2649 | 0.030 |
Why?
|
| Ribosome Subunits, Small, Eukaryotic | 1 | 2015 | 19 | 0.030 |
Why?
|
| Simian immunodeficiency virus | 1 | 2001 | 846 | 0.030 |
Why?
|
| Geography | 1 | 2017 | 669 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 491 | 0.030 |
Why?
|
| RNA, Ribosomal | 1 | 2015 | 246 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2020 | 3701 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2017 | 4560 | 0.030 |
Why?
|
| Cell Line | 2 | 2012 | 15997 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2017 | 959 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2015 | 5456 | 0.030 |
Why?
|
| Plasmodium berghei | 1 | 2014 | 168 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 1213 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 1549 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2015 | 571 | 0.030 |
Why?
|
| Atovaquone | 1 | 2011 | 58 | 0.030 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2011 | 83 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2008 | 1723 | 0.030 |
Why?
|
| Genes, Protozoan | 1 | 2012 | 163 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2012 | 18111 | 0.030 |
Why?
|
| Base Sequence | 1 | 2002 | 12797 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2012 | 562 | 0.020 |
Why?
|
| Genome, Protozoan | 1 | 2012 | 142 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2021 | 4026 | 0.020 |
Why?
|
| Indophenol | 1 | 2008 | 6 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2017 | 2751 | 0.020 |
Why?
|
| Vitamin K 3 | 1 | 2008 | 15 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 13815 | 0.020 |
Why?
|
| Onium Compounds | 1 | 2008 | 31 | 0.020 |
Why?
|
| Phenol | 1 | 2008 | 43 | 0.020 |
Why?
|
| Boston | 1 | 2021 | 9313 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2008 | 459 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2012 | 1266 | 0.020 |
Why?
|
| Electrons | 1 | 2008 | 268 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2017 | 1978 | 0.020 |
Why?
|
| Proteins | 1 | 2003 | 6103 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2014 | 1211 | 0.020 |
Why?
|
| Leukocidins | 1 | 2006 | 17 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2006 | 143 | 0.020 |
Why?
|
| Hawaii | 1 | 2006 | 105 | 0.020 |
Why?
|
| Exotoxins | 1 | 2006 | 119 | 0.020 |
Why?
|
| Point Mutation | 1 | 2012 | 1623 | 0.020 |
Why?
|
| Alleles | 1 | 2017 | 6933 | 0.020 |
Why?
|
| Phenotype | 1 | 2023 | 16365 | 0.020 |
Why?
|
| Quinolones | 1 | 2008 | 367 | 0.020 |
Why?
|
| Chromosomes, Bacterial | 1 | 2006 | 282 | 0.020 |
Why?
|
| Movement | 1 | 2012 | 1471 | 0.020 |
Why?
|
| Mice | 3 | 2020 | 81183 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6622 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2008 | 913 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 1375 | 0.010 |
Why?
|
| Binding Sites | 1 | 2011 | 6114 | 0.010 |
Why?
|
| Child | 3 | 2020 | 77709 | 0.010 |
Why?
|
| Adolescent | 3 | 2020 | 85781 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2009 | 2263 | 0.010 |
Why?
|
| Gene Products, nef | 1 | 2001 | 110 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5535 | 0.010 |
Why?
|
| Bacterial Toxins | 1 | 2006 | 931 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2006 | 1877 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2001 | 547 | 0.010 |
Why?
|
| Codon | 1 | 2001 | 611 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 936 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 40561 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2001 | 2256 | 0.010 |
Why?
|
| Tyrosine | 1 | 2001 | 1461 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2008 | 4217 | 0.010 |
Why?
|
| Adult | 3 | 2020 | 214055 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2001 | 1539 | 0.010 |
Why?
|
| Male | 3 | 2021 | 350118 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2001 | 3128 | 0.010 |
Why?
|
| HIV Infections | 1 | 2001 | 16718 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2001 | 2375 | 0.010 |
Why?
|
| Female | 3 | 2021 | 380194 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2001 | 1836 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 19905 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 7181 | 0.000 |
Why?
|
| Incidence | 1 | 2006 | 20947 | 0.000 |
Why?
|
| Young Adult | 1 | 2014 | 56430 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2006 | 25625 | 0.000 |
Why?
|
| Infant | 1 | 2006 | 35136 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2006 | 41006 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2001 | 10180 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 57776 | 0.000 |
Why?
|
| Aged | 1 | 2006 | 163280 | 0.000 |
Why?
|
| Middle Aged | 1 | 2006 | 213383 | 0.000 |
Why?
|